84 related articles for article (PubMed ID: 26188133)
1. Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.
Nagai N; Ju M; Izumi-Nagai K; Robbie SJ; Bainbridge JW; Gale DC; Pierre E; Krauss AH; Adamson P; Shima DT; Ng YS
Am J Pathol; 2015 Sep; 185(9):2534-49. PubMed ID: 26188133
[TBL] [Abstract][Full Text] [Related]
2. Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage.
Li Y; Guo S; Wu X; Wan J; Guan Y; Luo C; Chen Q; Jiang H; Lin H; Qian H; Shi W; Fan W
Bioorg Chem; 2024 Jun; 147():107405. PubMed ID: 38696843
[TBL] [Abstract][Full Text] [Related]
3. Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization.
Liu CH; Yemanyi F; Bora K; Kushwah N; Blomfield AK; Kamenecka TM; SanGiovanni JP; Sun Y; Solt LA; Chen J
Aging (Albany NY); 2023 Jan; 15(1):37-52. PubMed ID: 36626253
[TBL] [Abstract][Full Text] [Related]
4. JP1, a polypeptide specifically targeting integrin αVβ3, ameliorates choroidal neovascularization and diabetic retinopathy in mice.
Xie Z; Wu XJ; Cheng RW; Cui JH; Yuan ST; Zhou JW; Liu QH
Acta Pharmacol Sin; 2023 Apr; 44(4):897-912. PubMed ID: 36280689
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition.
Gonzalez-Buendia L; Delgado-Tirado S; An M; O'Hare M; Amarnani D; A B Whitmore H; Zhao G; Ruiz-Moreno JM; Arboleda-Velasquez JF; Kim LA
Am J Pathol; 2021 Mar; 191(3):418-424. PubMed ID: 33345998
[TBL] [Abstract][Full Text] [Related]
6. End binding-3 inhibitor activates regenerative program in age-related macular degeneration.
Lee Q; Chan WC; Qu X; Sun Y; Abdelkarim H; Le J; Saqib U; Sun MY; Kruse K; Banerjee A; Hitchinson B; Geyer M; Huang F; Guaiquil V; Mutso AA; Sanders M; Rosenblatt MI; Maienschein-Cline M; Lawrence MS; Gaponenko V; Malik AB; Komarova YA
Cell Rep Med; 2023 Oct; 4(10):101223. PubMed ID: 37794584
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate receptor 1/5 selective agonist alleviates ocular vascular pathologies.
Nakamura S; Yamamoto R; Matsuda T; Yasuda H; Nishinaka A; Takahashi K; Inoue Y; Kuromitsu S; Shimazawa M; Goto M; Narumiya S; Hara H
Sci Rep; 2024 Apr; 14(1):9700. PubMed ID: 38678148
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of telomerase ameliorates experimental choroidal neovascularization.
Kumar A; Nagasaka Y; Jayananthan V; Zidan A; Heisler-Taylor T; Ambati J; Tamiya S; Kerur N
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167156. PubMed ID: 38582267
[TBL] [Abstract][Full Text] [Related]
9. 5-Aza-2'-Deoxycytidine Ameliorates Choroidal Neovascularization by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Wu X; Yang X; Dai X; Chen X; Shen M; Dai J; Yuan F; Wang L; Yuan Y; Feng Y
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):23. PubMed ID: 38345554
[TBL] [Abstract][Full Text] [Related]
10. Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis.
Zhang JY; Xiao J; Xie B; Barba H; Boachie-Mensah M; Shah RN; Nadeem U; Spedale M; Dylla N; Lin H; Sidebottom AM; D'Souza M; Theriault B; Sulakhe D; Chang EB; Skondra D
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):21. PubMed ID: 38108689
[TBL] [Abstract][Full Text] [Related]
11. Targeted long-term noninvasive treatment of choroidal neovascularization by biodegradable nanoparticles.
Yao H; Xu H; Wu M; Lei W; Li L; Liu D; Wang Z; Ran H; Ma H; Zhou X
Acta Biomater; 2023 Aug; 166():536-551. PubMed ID: 37196903
[TBL] [Abstract][Full Text] [Related]
12. A Sustainable Retinal Drug Co-Delivery for Boosting Therapeutic Efficacy in wAMD: Unveiling Multifaceted Evidence and Synergistic Mechanisms.
Liu C; Su W; Jiang X; Lv Y; Kong F; Chen Q; Zhang Q; Zhang H; Liu Y; Li X; Xu X; Chen Y; Qu D
Adv Healthc Mater; 2024 Jun; 13(14):e2303659. PubMed ID: 38386849
[TBL] [Abstract][Full Text] [Related]
13. Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia/reperfusion.
Canonica J; Foxton R; Garrido MG; Lin CM; Uhles S; Shanmugam S; Antonetti DA; Abcouwer SF; Westenskow PD
Front Cell Neurosci; 2023; 17():1192464. PubMed ID: 37377777
[TBL] [Abstract][Full Text] [Related]
14. Minocycline and Diacetyl Minocycline Eye Drops Reduce Ocular Neovascularization in Mice.
Willms JO; Mitchell K; Shashtri M; Sundin O; Liu X; Panthagani P; Tran P; Navarro S; Sniegowski C; Shaik AA; Chaudhury T; Reid TW; Bergeson SE
Transl Vis Sci Technol; 2023 Dec; 12(12):10. PubMed ID: 38064336
[TBL] [Abstract][Full Text] [Related]
15. A Validated Phenotyping Algorithm for Genetic Association Studies in Age-related Macular Degeneration.
Simonett JM; Sohrab MA; Pacheco J; Armstrong LL; Rzhetskaya M; Smith M; Geoffrey Hayes M; Fawzi AA
Sci Rep; 2015 Aug; 5():12875. PubMed ID: 26255974
[TBL] [Abstract][Full Text] [Related]
16. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.
Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME
PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice.
Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y
Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500
[TBL] [Abstract][Full Text] [Related]
18. CCR3 Expression in Relation to Delayed Microbleeds in a Rat Model of Large Vessel Occlusion.
Claypoole SM; Frank JA; Messmer SJ; Pennypacker KR
J Exp Neurol; 2024; 5(1):1-8. PubMed ID: 38332938
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods.
Bora K; Kushwah N; Maurya M; Pavlovich MC; Wang Z; Chen J
Cells; 2023 Oct; 12(20):. PubMed ID: 37887287
[TBL] [Abstract][Full Text] [Related]
20. Choroidal neovascularization removal with photo-mediated ultrasound therapy.
Wang M; Nguyen VP; Singh R; Mossallam B; Yang X; Wang X; Paulus YM
Med Phys; 2023 Jun; 50(6):3661-3670. PubMed ID: 37029733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
